By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cellectis today said that it has licensed intellectual property covering induced Pluripotent Stem Cells (iPSCs) from iPS Academia Japan.

The non-exclusive licensing deals cover research conducted by Shinya Yamanaka of the Center for iPS Cell Research and Application at Kyoto University in Japan. iPS Academia Japan is an affiliate of Kyoto University established in 2008 to manage IP covering iPSC technologies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.